Results 191 to 200 of about 65,038 (202)

Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL

OncoImmunology, 2018
Gonzalo Blanco, Anna Vardi, Anna Puiggros   +2 more
exaly  

Author's Reply: CML as a Second Cancer after CLL

Ca-A Cancer Journal for Clinicians, 1981
exaly  

A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154

Leukemia, 2010
Deepa Sampath
exaly  

CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3

Leukemia and Lymphoma, 1991
exaly  

Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan

European Journal of Haematology, 2001
exaly  

Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases

British Journal of Haematology, 1997
exaly  

Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study

Journal of Hematology and Oncology
Enrico Gaffo, Stefania Bortoluzzi
exaly  

B-CLL with surface IgM kappa phenotype.

British journal of haematology, 1988
C S, Chapman, M E, Gooch, D E, Shaw, A C, Campbell   +3 more
openaire   +1 more source

B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules

Leukemia, 2002
exaly  

Angiopoietins Modulate Survival, Migration, and the Components of the Ang-Tie2 Pathway of Chronic Lymphocytic Leukaemia (CLL) Cells In Vitro

Cancer Microenvironment, 2016
exaly